切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2015, Vol. 04 ›› Issue (05) : 268 -273. doi: 10.3877/cma.j.issn.2095-3232.2015.05.004

所属专题: 文献

临床研究

原发性肝癌三维可视化诊治平台的构建及临床应用
祝文1, 方驰华1,(), 范应方1, 杨剑1, 项楠1, 曾宁1, 方兆山1, 陈青山1   
  1. 1. 510282 广州,南方医科大学珠江医院肝胆一科
  • 收稿日期:2015-06-15 出版日期:2015-10-10
  • 通信作者: 方驰华
  • 基金资助:
    国家高技术研究发展(863)计划(2012AA021105); 国家自然科学基金重点项目(U1401254); 广东省重大科技专项(2012A080203013)

Construction and clinical application of three-dimensional visualization platform in diagnosis and treatment of primary liver cancer

Wen Zhu1, Chihua Fang1,(), Yingfang Fan1, Jian Yang1, Nan Xiang1, Ning Zeng1, Zhaoshan Fang1, Qingshan Chen1   

  1. 1. Department of Hepatobiliary Surgery, Zhujiang Hospital of Southern Medical University, Guangzhou 510282, China
  • Received:2015-06-15 Published:2015-10-10
  • Corresponding author: Chihua Fang
  • About author:
    Corresponding author: Fang Chihua, Email:
引用本文:

祝文, 方驰华, 范应方, 杨剑, 项楠, 曾宁, 方兆山, 陈青山. 原发性肝癌三维可视化诊治平台的构建及临床应用[J/OL]. 中华肝脏外科手术学电子杂志, 2015, 04(05): 268-273.

Wen Zhu, Chihua Fang, Yingfang Fan, Jian Yang, Nan Xiang, Ning Zeng, Zhaoshan Fang, Qingshan Chen. Construction and clinical application of three-dimensional visualization platform in diagnosis and treatment of primary liver cancer[J/OL]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2015, 04(05): 268-273.

目的

探讨原发性肝癌三维可视化诊治平台的构建及临床应用价值。

方法

本前瞻性研究对象为2012年1月至2014年12月在南方医科大学珠江医院诊治的56例肝癌患者。所有患者均签署知情同意书,符合医学伦理学规定。其中男49例,女7例;平均年龄(47±7)岁。对患者行256层螺旋CT扫描,收集患者平扫期、动脉期、门静脉期和肝静脉期薄层CT数据。将数据导入医学图像三维可视化系统(MI-3DVS),分别对肝脏、肿瘤组织、门静脉系统、肝静脉系统、肝动脉系统及肝脏周围脏器行图像分割和三维可视化分析。然后行个体化肝脏分段、脉管及肝中叶肿瘤分型、个体化体积计算。通过模拟多种仿真手术进行手术规划,选择合理手术方式。对复杂性肝切除患者进行肝脏3D打印。

结果

56例患者均完成三维可视化模型的构建,可清晰显示肝内各血管系统解剖形态、肿瘤部位及大小,进行肝脏个体化分段,脉管及肝中叶肿瘤分型。经个体化体积计算,患者全肝体积中位数为1 215(1 025~1 856)ml,肝肿瘤体积368(25~653)ml,虚拟切除肝体积478(125~854)ml。56例患者均完成肿瘤根治性切除,实际手术与术前手术规划一致,其中11例复杂性肝切除患者3D打印模型与术中所见完全一致。全部患者手术顺利,无发生围手术期死亡。6例患者术后出现胸腔积液,1例出现肝断面胆漏,经对症治疗后治愈。

结论

原发性肝癌三维可视化诊治平台可实现术前精确诊断,术中精准操作,提高手术成功率。

Objective

To investigate the construction and clinical application of three-dimensional visualization platform in diagnosis and treatment of primary liver cancer.

Methods

Fifty-six patients with liver cancer diagnosed and treated in Zhujiang Hospital of Southern Medical University between January 2012 and December 2014 were enrolled in this prospective study. The informed consents of all patients were obtained and the local ethical committee approval had been received. Among the 56 patients, 49 were males and 7 were females with the average age of (47±7) years old. The 256-slice spiral CT scan was performed on the patients to collect plain scan data and thin-layer CT data of arterial phase, portal venous phase and hepatic venous phase. The data were imported into the Medical Image Three-dimensional Visualization System (MI-3DVS) to perform image segmentation and three-dimensional visualization analysis of the liver, tumor tissues, portal venous system, hepatic venous system, hepatic arterial system and organs around the liver. The individualized liver segmentation, classification of the vascular and middle lobe tumor was performed and individualized volume was calculated. The surgical planning was formulated through simulating multiple surgery and the rational surgical procedure was selected. For patients undergoing complex hepatectomy, three-dimensional liver model was printed.

Results

The construction of three-dimensional visualization model of all 56 patients was completed, which could clearly display the anatomical morphology of each vascular system, the location and size of tumor, and perform individual liver segmentation as well as vascular, middle lobe tumor classification. According to individualized volume calculation, the median total liver volume was 1 215 (1 025-1 856) ml, the liver tumor volume was 368 (25-653) ml and the virtual removal liver volume was 478 (125-854) ml. All the 56 patients received radical resection of tumor. The actual operation was in accordant with the preoperative surgical plan. The 3D printing model of 11 patients undergoing complex hepatectomy was exactly the same with that observed during the operation. The operations of all patients were completed successfully and no death was observed during the perioperative period. Six patients developed pleural effusion and one developed bile leakage on the liver cutting surface after operation. These patients were cured after symptomatic treatments.

Conclusion

Three-dimensional visualization platform for diagnosis and treatment of primary liver cancer can realize the precise preoperative diagnosis and intraoperative manipulation, thus enhances the success rate of surgery.

图1 肝癌三维可视化诊治平台构建路线图
图4 肝肿瘤与脉管3D打印模型
[1]
El-Serag HB. Hepatocellular carcinoma[J]. N Engl J Med, 2011, 365(12): 1118-1127.
[2]
吴孟超.肝癌在中国[J/CD].中华肝脏外科手术学电子杂志,2012, 1(1):3-4.
[3]
Simpson AL, Geller DA, Hemming AW, et al. Liver planning software accurately predicts postoperative liver volume and measures early regeneration[J]. J Am Coll Surg, 2014, 219(2): 199-207.
[4]
Fang CH, Tao HS, Yang J, et al. Impact of three-dimensional reconstruction technique in the operation planning of centrally located hepatocellular carcinoma[J]. J Am Coll Surg, 2015, 220 (1): 28-37.
[5]
方驰华,项楠.数字化微创技术在肝胆胰外科的应用[J].中国微创外科杂志,2011, 11(1):15-19.
[6]
Fang CH, You JH, Lau WY, et al. Anatomical variations of hepatic veins: three-dimensional computed tomography scans of 200 subjects[J]. World J Surg, 2012, 36(1): 120-124.
[7]
杨剑,方驰华,范应方,等.基于亚毫米CT扫描数据的肝外胆管供血动脉三维可视化模型构建[J].南方医科大学学报,2014, 34 (7):945-949.
[8]
Yang J, Fang CH, Fan YF, et al. To assess the benefits of medical image three-dimensional visualization system assisted pancreaticoduodenctomy for patients with hepatic artery variance[J]. Int J Med Robot, 2014, 10 (4): 410-417.
[9]
范应方,项楠,蔡伟,等.三维可视化技术在精准肝切除术前规划中的应用[J/CD].中华肝脏外科手术学电子杂志,2014, 3(5): 271-275.
[10]
方驰华,冯石坚,范应方,等.三维可视化技术在评估残肝体积及指导肝切除中的应用研究[J].肝胆外科杂志,2012, 20(2):95-98.
[11]
方驰华,方兆山,范应方,等. 三维可视化、3D打印及3D腹腔镜在肝肿瘤外科诊治中的应用[J].南方医科大学学报,2015, 35(5): 639-645.
[12]
López-Andújar R, Moya A, Montalvá E, et al. Lessons learned from anatomic variants of the hepatic artery in 1,081 transplanted livers[J]. Liver Transpl, 2007,13 (10):1401-1404.
[13]
Wang Y, Zhang Y, Peitgen HO, et al. Precise local resection for hepatocellular carcinoma based on tumor-surrounding vascular anatomy revealed by 3D analysis[J]. Dig Surg, 2012, 29 (2): 99-106.
[14]
Michalski MH, Ross JS. The shape of things to come: 3D printing in medicine[J]. JAMA, 2014, 312 (21): 2213-2214.
[15]
Ventola CL. Medical applications for 3D printing: current and projected uses[J]. PT, 2014, 39 (10): 704-711.
[16]
李振化,王桂华.3D打印技术在医学中的应用研究进展[J].实用医学杂志,2015 (7): 1203-1205.
[17]
管吉,杨树欣,管叶,等.3D打印技术在医疗领域的研究进展[J].中国医疗设备,2014, 29 (4): 71-72.
[18]
董文兴,刘斌.3D打印技术在骨科医疗器械的应用现状分析[J].生物骨科材料与临床研究,2014, 11(4): 39-41.
[19]
Esses SJ, Berman P, Bloom AI, et al. Clinical applications of physical 3D models derived from MDCT data and created by rapid prototyping[J]. AJR Am J Roentgenol, 2011, 196 (6): W683-688.
[20]
Zein NN, Hanouneh IA, Bishop PD, et al. Three-dimensional print of a liver for preoperative planning in living donor liver transplantation[J]. Liver Transpl, 2013, 19 (12): 1304-1310.
[1] 王亚红, 蔡胜, 葛志通, 杨筱, 李建初. 颅骨骨膜窦的超声表现一例[J/OL]. 中华医学超声杂志(电子版), 2024, 21(11): 1089-1091.
[2] 李华志, 曹广, 刘殿刚, 张雅静. 不同入路下行肝切除术治疗原发性肝细胞癌的临床对比[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 52-55.
[3] 常小伟, 蔡瑜, 赵志勇, 张伟. 高强度聚焦超声消融术联合肝动脉化疗栓塞术治疗原发性肝细胞癌的效果及安全性分析[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 56-59.
[4] 赵林娟, 吕婕, 王文胜, 马德茂, 侯涛. 超声引导下染色剂标记切缘的梭柱型和圆柱型保乳区段切除术的效果研究[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 634-637.
[5] 屈翔宇, 张懿刚, 李浩令, 邱天, 谈燚. USP24及其共表达肿瘤代谢基因在肝细胞癌中的诊断和预后预测作用[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 659-662.
[6] 熊鹰, 林敬莱, 白奇, 郭剑明, 王烁. 肾癌自动化病理诊断:AI离临床还有多远?[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 535-540.
[7] 王秋生. 胆道良性疾病诊疗策略[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 779-782.
[8] 中华医学会器官移植学分会. 肝移植术后缺血性胆道病变诊断与治疗中国实践指南[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 739-748.
[9] 郑大雯, 王健东. 胆囊癌辅助诊断研究进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 769-773.
[10] 公宇, 廖媛, 尚梅. 肝细胞癌TACE术后复发影响因素及预测模型建立[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 818-824.
[11] 李浩, 陈棋帅, 费发珠, 张宁伟, 李元东, 王硕晨, 任宾. 慢性肝病肝纤维化无创诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 863-867.
[12] 谭瑞义. 小细胞骨肉瘤诊断及治疗研究现状与进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(08): 781-784.
[13] 王子阳, 王宏宾, 刘晓旌. 血清标志物对甲胎蛋白阴性肝细胞癌诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 677-681.
[14] 陈慧, 邹祖鹏, 周田田, 张艺丹, 张海萍. 皮肤镜对头皮红斑性皮肤病辅助鉴别诊断的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 692-698.
[15] 胡云鹤, 周玉焯, 付瑞瑛, 于凡, 李爱东. CHS-DRG付费制度下GB1分组住院费用影响因素分析与管理策略探讨[J/OL]. 中华临床医师杂志(电子版), 2024, 18(06): 568-574.
阅读次数
全文


摘要